Status:
UNKNOWN
The Effects of I Quit Ordinary Smoking on the Arterial Wall and Endothelial Glycocalyx Properties of Smokers
Lead Sponsor:
University of Athens
Conditions:
Smoking Cessation
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
I quit ordinary smoking (IQOS) is proposed as a bridge to smoking cessation. In this study the investigators will examine its effects on aortic elasticity, glycocalyx integrity, and exhaled carbon mon...
Detailed Description
Two smokers groups matched for age and sex will be assessed: 1. a group of 30 current smokers with no diagnosed cardiovascular disease as the control group for chronic phase 2. a group of 30 current ...
Eligibility Criteria
Inclusion
- Active conventional cigarette smoker
Exclusion
- Health condition adversely affected by smoking
- History or presence of cardiovascular disease
Key Trial Info
Start Date :
March 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03452124
Start Date
March 30 2018
End Date
June 30 2021
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
"Attikon" University General Hospital
Athens, Attica, Greece, 12462